Advertisements


Aptose says CG"806 kills cancer cells resistant to other FLT3, BTK inhibitors

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 16th, 2018

Scientists Want to Create Human Cells That Are Resistant to Viruses

First step, virus resistant; next step, cancer......»»

Category: topSource: newsweekMay 2nd, 2018

Wistar’s Zachary Schug and lab are studying the relationship between alcohol intake and some site-specific cancers

What do cancer cells need to thrive and grow? The Wistar Institute’s Dr. Zachary Schug — assistant professor in the Molecular and Cellular Oncogenesis Program at Wistar’s Ellen and Ronald Caplan Cancer Center — studies how cancer cells’ m.....»»

Category: topSource: bizjournalsApr 24th, 2024

Aravive Reports Fourth Quarter and Twelve Months Ended December 31, 2019 Financial Results and Provides Recent Corporate Updates

AVB-500 Phase 1b dose escalation ongoing at 20 mg/kg dose in platinum resistant ovarian cancer with potential for topline data in summer 2020 C.....»»

Category: earningsSource: benzingaMar 27th, 2020

The most mind-blowing human health discoveries of 2019

Department of Foreign Affairs and Trade/flickr In 2019, science and health experts learned more about the best ways to eat, how immune cells can be programmed to fight cancer, and why vaping might be more dangerous th.....»»

Category: topSource: businessinsiderDec 23rd, 2019

Why Accelerated Approval Could Be Huge for This Ovarian Cancer Study

ImmunoGen shares jumped on Tuesday after the FDA advised that a new single-arm study in platinum-resistant ovarian cancer could support accelerated approval......»»

Category: blogSource: 247wallstDec 17th, 2019

Veru Reports Fiscal 2019 Full-Year Net Revenues Doubled, Gross Profit Up 147%

--Update on Ongoing Phase 1b/2 VERU-111, Oral Selective Antitubulin, Clinical Trial Demonstrates Antitumor Activity and No Dose Related Toxicity Reached in Men with Metastatic Castration Resistant Prostate Cancer-- --VERU-111 Has Promisin.....»»

Category: earningsSource: benzingaDec 12th, 2019

Aptose Shoots Up As Investors Focus On Reversible BTK Inhibitors

Aptose Shoots Up As Investors Focus On Reversible BTK Inhibitors.....»»

Category: topSource: seekingalphaDec 10th, 2019

CAR T-Cells: The New Living Drug for Cancer Treatment Available at the Cancer Center of Kansas

Bassam Mattar, MD, FACP Overview of Cancer Treatments The field of oncology has treated cancer through various forms of chemotherapy and radiation since its beginning. Chemotherapy works by administering drugs to the patient to attack the dividi.....»»

Category: topSource: bizjournalsNov 8th, 2019

Duke University trustee awarded Nobel Prize for research that could help fight cancer

A trustee of Duke University has earned the prestigious Nobel Prize for his work on how cells sense oxygen in the body.  William Kaelin, one of Duke's newest trustees, has been announced as a recipient of the Nobel Prize for Physiology or Medicine. H.....»»

Category: topSource: bizjournalsOct 7th, 2019

21 Common and Controversial Blood Cancer Risk Factors

People can’t see the different components in the blood that keep the body healthy. But these components — mainly white and red blood cells, plasma, and platelets — can all become........»»

Category: blogSource: 247wallstSep 6th, 2019

Frozen assets: How a startup wants to cryobank your cells to fight cancer in the future

The Florida startup has Bay Area investors and is aiming straight at people willing to pay thousands of dollars to beat cancer in the future......»»

Category: topSource: bizjournalsAug 16th, 2019

Antibiotic-Resistant Superbugs Could Become A Bigger Killer Than Cancer

Authored by Mac.....»»

Category: blogSource: zerohedgeApr 23rd, 2019

Beautiful Images Show Cancer Sweeping Through Blood, Immune Cells Eating Sugar in Real-Time

We can see detailed images of cells in their natural environment, not just on a glass slide......»»

Category: topSource: newsweekApr 23rd, 2018

Fit & Proper: Lifestyle changes that may help prevent cancer

Cancer cells thrive in acidic environments. It promotes tumor growth and is a breeding ground for almost all viruses, pathogens and bacteria.....»»

Category: topSource: business-standardApr 21st, 2018

Immune therapy doubles lung cancer survival rate

New drugs that trigger a patient’s immune system to kill malignant cells can greatly improve the survival rate of people with the most common type of lung cancer, a new study found. The study, published in the New England Journal of Medicine, found.....»»

Category: topSource: bizjournalsApr 17th, 2018

Morgan Stanley Upgrades Loxo On The Potential Of A Targeted Cancer Therapy

Loxo Oncology Inc (NASDAQ: LOXO) holds an opportunity to differentiate itself among RET inhibitors while developing medicines for patients with genetically defined cancers, according to Morgan Stanley.  Latest Ratings for LO.....»»

Category: blogSource: benzingaApr 16th, 2018

Tea Leaf Nanoparticles Destroy Up to 80 Percent of Lung Cancer Cells

Scientists think these particles might be useful for computers, solar cells and medical applications......»»

Category: topSource: newsweekMay 21st, 2018

Studies indicate CRISPR edited cells may up cancer risk, STAT reports

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 11th, 2018

CRISPR Crashes After Study Highlights Potential Cancer Risk From Gene-Editing

Don't mess with mother nature.. or crowded longs! Crispr Therapeutics led gene-editing stocks lower after new studies published by Nature Medicine found that cells whose genomes are edited with the CRISPR-Cas9 technology have the po.....»»

Category: blogSource: zerohedgeJun 11th, 2018

Is CRISPR in Touble After New STAT Report?

Shares of CRISPR Therapeutics tumbled after a report was released that gene-edited cells might cause cancer. The implications of this study could be catastrophic for the company seeing as CRISPR is........»»

Category: blogSource: 247wallstJun 11th, 2018